No cannabis for scientific studies, says parliament
Legal cannabis has boomed in Switzerland, but the 'real' stuff remains proscribed.
Keystone
The Swiss parliament has rejected a motion to allow the use of cannabis in scientific studies investigating the drug’s effects. Opponents saw the motion as a back-door path towards liberalization.
After a narrow victory at the committee stage, the motion was rejected on Monday in the House of Representatives by another slim margin: 96 votes to 93, with two abstentions.
The conservative-right Swiss People’s Party and centrist Christian Democrats voted en masse against the idea, which they saw as an implicit route towards liberalising cannabis consumption.
Supporters of the project, which aimed to make cannabis available for academic studies about the effects of prescribed versions of the drug, had claimed that it would allow for a better understanding of possible health and social problems.
The vote comes after a November 2017 federal decision to block a University of Bern study – requested by the city’s authorities – into possible effects of the regulated sale of cannabis in pharmacies.
At the time, the Federal Office of Public Health (despite not rejecting the project in principle) said the request could not be granted as “current drugs legislation does not allow the use of cannabis for non-medical reasons […] For such a study to be permitted, the law would have to be supplemented by a special legal provision for scientific pilot projects,” it wrote.
Monday’s decision thus eliminated the possibility, for now, of such a legal provision being enacted.
Growing, consuming and dealing cannabis are all forbidden in Switzerland. In 2008, almost two-thirds of Swiss voters rejected a people’s initiative calling for the decriminalisation of consumption.
Meanwhile, legal cannabis has become a flourishing business in Switzerland since it a 2011 decision to let adults buy and use cannabis with up to 1% tetrahydrocannabinol (THC) – the active ingredient that gets smokers high.
More
More
How legal cannabis is changing Switzerland
This content was published on
What effect is CBD having on the Swiss economy and the legal system?
Is reforming the Swiss pension system still possible, and if so, how?
Solutions still need to be found to meet the challenge of an ageing population and to improve the pensions of low-paid workers, the majority of whom are women.
This content was published on
The suspension of asylum procedures decided Monday following the fall of Bashar al-Assad affects 500 Syrian applicants in Switzerland.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
‘Swiss marijuana champion’ finds new markets with ‘cannabis light’
This content was published on
There’s decaffeinated coffee, alcohol-free beer, and now marijuana that doesn’t make you high. A producer reveals the hidden side of the market.
Legal marijuana could earn millions for Swiss state
This content was published on
Some 130 firms have registered with the Swiss federal authorities to sell legal pot that could generate CHF30 million ($30.2 million) in revenue.
This content was published on
In Switzerland, 15% of 15-year-old boys and 9% of girls said they had used cannabis in the past 30 days, according to the WHO studyExternal link, based on data from 42 countries from 2014. Switzerland was pipped by young stoners from France (16% of boys) and was level with Italy (15% of boys). In addition,…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.